2315.HK
2315.HK
CNE100005D27
BIOCYTOGEN-B
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 1.378.808.000 980.454.000
40.6%
Cost of Revenue 333.218.000 218.935.000
52.2%
Gross Profit 1.045.590.000 761.519.000
37.3%
766.991.000 611.314.000
25.5%
Operating Income 278.599.000 150.205.000
85.5%
Pretax Income 188.030.000 42.940.000
337.9%
Net Income Common Stockholders 173.199.000 33.542.000
416.4%
-- --
--
-- --
--
ende